Parexel China
International full-service CRO with China delivery and published early-phase partner-site information. Confirm the actual team, indication and protocol rather than assuming global coverage establishes IIT fit.
Corporate information
- Company entity
- Parexel China
- Headquarters / principal office
- Raleigh, North Carolina, United States (current investor profile) ↗
- Founded
- 1982 ↗
- Ownership / capital status
- PrivatePrivate CRO backed by EQT and Goldman Sachs Asset Management ↗
- Official corporate reference
- https://www.parexel.com/about-us/global-reach ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-06 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Public evidence snapshot
International full-service CRO with China delivery and published early-phase partner-site information. Confirm the actual team, indication and protocol rather than assuming global coverage establishes IIT fit.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- Parexel China — Official clinical services / corporate disclosure
- Parexel China — Official clinical services / corporate disclosure